The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solutionResearch in context

Authors :: Allison F. O’Neill
Angela Trobaugh-Lotrario
James I. Geller
Eiso Hiyama
Kenichiro Watanabe
Isabelle Aerts
Brice Fresneau
Fabienne Toutain
Michael J. Sullivan
Howard M. Katzenstein
Bruce Morland
Sophie Branchereau
József Zsiros
Rudolf Maibach
Marc Ansari
Source :: EClinicalMedicine, Vol 69, Iss , Pp 102446- (2024)
Publication Year :: 2024
Publisher :: Elsevier, 2024.
Abstract: Summary: Liver tumors account for approximately 2% of all pediatric malignancies. Children with advanced stages of hepatoblastoma (HB) are cured only 50–70% of the time while children with advanced hepatocellular carcinoma (HCC) have a

Subjects :: Review
Pediatric
Relapse
Hepatoblastoma
Carcinoma
Registry
Medicine (General)
R5-920

Full Text Access

Tools